alanyl-glutamyl-aspartyl-glycine has been researched along with Cancer of Colon in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anisimov, V; Ben-Hur, H; Khavinson, V; Kossoy, G; Popovich, I; Tendler, E; Zabezhinski, M; Zandbank, J; Zusman, I | 1 |
| Anisimov, VN; Khavinson, VKh; Popovich, IG; Zabezhinski, MA | 1 |
2 other study(ies) available for alanyl-glutamyl-aspartyl-glycine and Cancer of Colon
| Article | Year |
|---|---|
Epitalon and colon carcinogenesis in rats: proliferative activity and apoptosis in colon tumors and mucosa.
Topics: 1,2-Dimethylhydrazine; Animals; Apoptosis; Carcinogens; Cell Division; Colonic Neoplasms; In Situ Nick-End Labeling; Lymphatic Metastasis; Male; Mitosis; Mucous Membrane; Oligopeptides; Peptides; Rats | 2003 |
Inhibitory effect of peptide Epitalon on colon carcinogenesis induced by 1,2-dimethylhydrazine in rats.
Topics: 1,2-Dimethylhydrazine; Animals; Anticarcinogenic Agents; Colonic Neoplasms; Injections, Subcutaneous; Male; Oligopeptides; Rats; Rats, Inbred Strains; Time Factors | 2002 |